Article info

Download PDFPDF
Experimental therapeutics: preclinical
B12 Treatment with arimoclomol does not lead to rescue of motor or striatal deficits in the YAC128 mouse model of Huntington's disease

Citation

Pouladi MA, Carroll J, dar Santos R, et al
B12 Treatment with arimoclomol does not lead to rescue of motor or striatal deficits in the YAC128 mouse model of Huntington's disease

Publication history

  • First published November 16, 2010.
Online issue publication 
November 16, 2010

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.